{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:20:12Z","timestamp":1793035212940,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00520-024-08623-y","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:02:01Z","timestamp":1719208921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of chemotherapy-induced nausea and vomiting guideline adherence in pediatric and adult patients: a systematic review"],"prefix":"10.1007","volume":"32","author":[{"given":"Marie Charlotte","family":"Renaux Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Lee","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the international Pediatric Oncology supportive care Guideline (iPOG) Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Behm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Bouttefroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Digout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejin","family":"Kebudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Orsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Poir\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Thouvenin-Doulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"8623_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2022.01.028","volume":"166","author":"M Aapro","year":"2022","unstructured":"Aapro M, Caprariu Z, Chilingirov P, Chrapava M, Curca RO, Gales L, Grigorescu AC, Huszno J, Karlinova B, Kellnerova R, Malejcikova M, Marinca M, Petru E, Pluzanski A, Pokorna P, Pribulova Z, Rubach M, Steger GG, Tesarova P, Valekova L, Yordanov N, Walaszkowska-Czyz A (2022) Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea\/emesis registry in oncology (NERO). Eur J Cancer 166:126\u2013133","journal-title":"Eur J Cancer"},{"key":"8623_CR2","doi-asserted-by":"crossref","unstructured":"Aapro M, Molassiotis A, Dicato M, Pelaez I, Rodriguez-Lescure A, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F, investigators P (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 23: 1986-1992","DOI":"10.1093\/annonc\/mds021"},{"key":"8623_CR3","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s11096-016-0393-3","volume":"38","author":"N Abunahlah","year":"2016","unstructured":"Abunahlah N, Sancar M, Dane F, Ozyavuz MK (2016) Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life. Int J Clin Pharm 38:1464\u20131476","journal-title":"Int J Clin Pharm"},{"key":"8623_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1078155212457966","volume":"19","author":"M Aseeri","year":"2013","unstructured":"Aseeri M, Mukhtar A, Al Khansa S, Elimam N, Jastaniah W (2013) A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center. J Oncol Pharm Pract 19:138\u2013144","journal-title":"J Oncol Pharm Pract"},{"key":"8623_CR5","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.12788\/jcso.0314","volume":"15","author":"DS Childs","year":"2017","unstructured":"Childs DS, Jacobson AC, Mitchell JL, Hubbard JM, Yoon HH, Finnes H, Grothey A, Jatoi A (2017) Prescriber adherence to antiemetic guidelines with the new agent trifuridine-tipiracil. J Community Support Oncol 15:e142\u2013e146","journal-title":"J Community Support Oncol"},{"key":"8623_CR6","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1007\/s00520-018-4259-1","volume":"26","author":"M De Laurentiis","year":"2018","unstructured":"De Laurentiis M, Bonfadini C, Lorusso V, Cilenti G, Di Rella F, Altavilla G, Otero M, Ardizzoia A, Marchetti P, Peverelli G, Amoroso D, Vecchio S, Fiorio E, Orecchia S (2018) Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study. Support Care Cancer 26:4021\u20134029","journal-title":"Support Care Cancer"},{"key":"8623_CR7","doi-asserted-by":"publisher","first-page":"e28170","DOI":"10.1002\/pbc.28170","volume":"67","author":"LL Dupuis","year":"2020","unstructured":"Dupuis LL, Robinson PD, van de Wetering MD, Tissing W, Seelisch J, Digout C, Sung L, Phillips R (2020) Lexicon for guidance terminology in pediatric hematology\/oncology: a white paper. Pediatr Blood Cancer 67:e28170","journal-title":"Pediatr Blood Cancer"},{"key":"8623_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/bmt.2017.112","volume":"52","author":"J Flank","year":"2017","unstructured":"Flank J, Sparavalo J, Vol H, Hagen L, Stuhler R, Chong D, Courtney S, Doyle JJ, Gassas A, Schechter T, Dupuis LL (2017) The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study. Bone Marrow Transplant 52:1294\u20131299","journal-title":"Bone Marrow Transplant"},{"key":"8623_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JOP.2012.000816","volume":"10","author":"JW Gilmore","year":"2014","unstructured":"Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J, Haislip ST, Perry T, Boozan TL, Meador K, Cao X, Burke TA (2014) Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE study. J Oncol Pract 10:68\u201374","journal-title":"J Oncol Pract"},{"key":"8623_CR10","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","volume":"17","author":"RJ Gralla","year":"1999","unstructured":"Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. Am J Clin Oncol J Clin Oncol 17:2971\u20132994","journal-title":"Am J Clin Oncol J Clin Oncol"},{"key":"8623_CR11","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00520-011-1278-6","volume":"20","author":"T Hayashi","year":"2012","unstructured":"Hayashi T, Ikesue H, Esaki T, Fukazawa M, Abe M, Ohno S, Tomizawa T, Oishi R (2012) Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation. Support Care Cancer 20:1805\u20131810","journal-title":"Support Care Cancer"},{"key":"8623_CR12","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s00520-017-3679-7","volume":"25","author":"T Hayashi","year":"2017","unstructured":"Hayashi T, Shimokawa M, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M (2017) A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting. Support Care Cancer 25:2707\u20132714","journal-title":"Support Care Cancer"},{"key":"8623_CR13","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00520-015-2801-y","volume":"23","author":"C Hernandez Torres","year":"2015","unstructured":"Hernandez Torres C, Mazzarello S, Ng T, Dranitsaris G, Hutton B, Smith S, Munro A, Jacobs C, Clemons M (2015) Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients\u2019 experience. Support Care Cancer 23:3341\u20133359","journal-title":"Support Care Cancer"},{"key":"8623_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s005200050157","volume":"6","author":"PJ Hesketh","year":"1998","unstructured":"Hesketh PJ, Gralla RJ, du Bois A, Tonato M (1998) Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer 6:221\u2013227","journal-title":"Support Care Cancer"},{"key":"8623_CR15","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH (2017) Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline. Update J Clin Oncol 35:3240\u20133261","journal-title":"Update J Clin Oncol"},{"key":"8623_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10147-015-0908-2","volume":"21","author":"H Iihara","year":"2016","unstructured":"Iihara H, Fujii H, Yoshimi C, Yamada M, Suzuki A, Matsuhashi N, Takahashi T, Yoshida K, Itoh Y (2016) Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy. Int J Clin Oncol 21:409\u2013418","journal-title":"Int J Clin Oncol"},{"key":"8623_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40360-015-0005-1","volume":"16","author":"M Inoue","year":"2015","unstructured":"Inoue M, Shoji M, Shindo N, Otsuka K, Miura M, Shibata H (2015) Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome. BMC Pharmacol Toxicol 16:5","journal-title":"BMC Pharmacol Toxicol"},{"key":"8623_CR18","unstructured":"IOM (Institute of Medicine) (2011) Clinical practice guidelines we can trust. The National Academies Press, Washington, DC"},{"issue":"4","key":"8623_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.36468\/pharmaceutical-sciences.567","volume":"81","author":"G Kandasamy","year":"2019","unstructured":"Kandasamy G, Sivanandy P, Khobrani M, Almaghaslah D, Almanasef M, Vasudevan R, Chinnadhurai M, Honey N (2019) Effectiveness of antiemetics in the management of chemotherapy-induced nausea and vomiting in cancer patients following chemotherapy guidelines. Indian J Pharm Sci 81(4):757\u2013765","journal-title":"Indian J Pharm Sci"},{"key":"8623_CR20","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00520-013-1801-z","volume":"21","author":"S Koch","year":"2013","unstructured":"Koch S, Wein A, Siebler J, Boxberger F, Neurath MF, Harich HD, Hohenberger W, Dorje F (2013) Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project. Support Care Cancer 21:2395\u20132402","journal-title":"Support Care Cancer"},{"key":"8623_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"8623_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/aam.aam_87_20","volume":"21","author":"KM Manyega","year":"2022","unstructured":"Manyega KM, Joseph BN, Rotkangmwa OC, Dapar MP (2022) Chemotherapy-Associated nausea and vomiting: a cross-sectional survey of occurrence and management patterns at jos university teaching hospital, Nigeria. Ann Afr Med 21:124\u2013131","journal-title":"Ann Afr Med"},{"key":"8623_CR23","doi-asserted-by":"publisher","first-page":"e27488","DOI":"10.1002\/pbc.27488","volume":"66","author":"K McKinnon","year":"2019","unstructured":"McKinnon K, Jupp J, Ghosh S, Digout C, Eason S, Romanick M (2019) Adherence to pediatric acute chemotherapy-induced nausea and vomiting guidelines in Canadian hospitals. Pediatr Blood Cancer 66:e27488","journal-title":"Pediatr Blood Cancer"},{"key":"8623_CR24","first-page":"1006","volume":"153","author":"R Nieuwlaat","year":"2007","unstructured":"Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, L\u00e9vy S, Crijns HJ (2007) Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation Am Heart J 153:1006\u20131012","journal-title":"The Euro Heart Survey on Atrial Fibrillation Am Heart J"},{"issue":"Suppl 1","key":"8623_CR25","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1007\/s00520-010-1036-1","volume":"19","author":"I Olver","year":"2011","unstructured":"Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G (2011) Antiemetic research: future directions. Support Care Cancer 19(Suppl 1):S49-55","journal-title":"Support Care Cancer"},{"key":"8623_CR26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"8623_CR27","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1200\/JOP.2016.019448","volume":"13","author":"VM Patil","year":"2017","unstructured":"Patil VM, Noronha V, Joshi A, Ramaswamy A, Gupta S, Sahu A, Doshi V, Gupta T, Rath S, Banavali S, Prabhash K (2017) Adherence to and implementation of ASCO Antiemetic guidelines in routine practice in a tertiary cancer center in India. J Oncol Pract 13:e574\u2013e581","journal-title":"J Oncol Pract"},{"key":"8623_CR28","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1200\/JOP.2016.019448","volume":"13","author":"VM Patil","year":"2017","unstructured":"Patil VM, Noronha V, Joshi A, Ramaswamy A, Gupta S, Sahu A, Doshi V, Gupta T, Rath S, Banavali S, Prabhash K (2017) Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India. J Oncol Pract 13:e574\u2013e581","journal-title":"J Oncol Pract"},{"key":"8623_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","volume":"99","author":"S Sommariva","year":"2016","unstructured":"Sommariva S, Pongiglione B, Tarricone R (2016) Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol 99:13\u201336","journal-title":"Crit Rev Oncol Hematol"},{"key":"8623_CR30","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"8623_CR31","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.21873\/anticanres.11254","volume":"36","author":"A Suzuki","year":"2016","unstructured":"Suzuki A, Kobayashi R, Fujii H, Iihara H, Takahashi T, Yoshida K, Itoh Y (2016) Control of nausea and vomiting in patients with colorectal cancer receiving chemotherapy with moderate emetic risk. Anticancer Res 36:6527\u20136533","journal-title":"Anticancer Res"},{"key":"8623_CR32","first-page":"250","volume":"74","author":"M Uchida","year":"2019","unstructured":"Uchida M, Nakamura T, Shima T, Mori Y, Yoshimoto G, Kato K, Shimokawa M, Hosohata K, Miyamoto T, Akashi K (2019) Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy. Pharmazie 74:250\u2013254","journal-title":"Pharmazie"},{"key":"8623_CR33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00520-015-2882-7","volume":"24","author":"J Vanbockstael","year":"2016","unstructured":"Vanbockstael J, Coquan E, Gouerant S, Allouache D, Faveyrial A, Noal S, Delcambre C, Galais MP, Heron JF, Lefebvre AC, Sevin E, Hrab I, Polycarpe F, Andre M, Kaluzinski L, Gervais R, Gunzer K, Vie B, Saucier G, Lemenand N, Grellard JM, Clarisse B, Dugue AE, Joly F (2016) How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study. Support Care Cancer 24:1131\u20131138","journal-title":"Support Care Cancer"},{"key":"8623_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/TCRM.S133820","volume":"13","author":"A Vazin","year":"2017","unstructured":"Vazin A, Eslami D, Sahebi E (2017) Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study. Ther Clin Risk Manag 13:1151\u20131157","journal-title":"Ther Clin Risk Manag"},{"key":"8623_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.breast.2009.12.006","volume":"19","author":"A W\u00f6ckel","year":"2010","unstructured":"W\u00f6ckel A, Kurzeder C, Geyer V, Novasphenny I, Wolters R, Wischnewsky M, Kreienberg R, Varga D (2010) Effects of guideline adherence in primary breast cancer\u2013a 5-year multi-center cohort study of 3976 patients. The Breast\u202f: Official J Euro Soc Mastology 19:120\u2013127","journal-title":"The Breast : Official J Euro Soc Mastology"},{"key":"8623_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jamainternmed.2013.2921","volume":"173","author":"JD Wright","year":"2013","unstructured":"Wright JD, Neugut AI, Ananth CV, Lewin SN, Wilde ET, Lu Y-S, Herzog TJ, Hershman DL (2013) Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Intern Med 173:559\u2013568","journal-title":"JAMA Intern Med"},{"key":"8623_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00520-014-2372-3","volume":"23","author":"S Yu","year":"2015","unstructured":"Yu S, Burke TA, Chan A, Kim HK, Hsieh RK, Hu X, Liang JT, Banos A, Spiteri C, Keefe DM (2015) Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy\u2013a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines. Support Care Cancer 23:273\u2013282","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08623-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:18:25Z","timestamp":1721035105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["8623"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08623-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L. Lee Dupuis is a Deputy Associate\u00a0Editor of Supportive Care in Cancer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}